Spruce Biosciences, Inc. Interest Expense, Long-term Debt
Spruce Biosciences, Inc. (SPRB) reported Interest Expense, Long-term Debt of $623.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseLongTermDebt · last filed 2026-08-12
- Spruce Biosciences, Inc. interest expense, long-term debt for the quarter ending 2026-06-30 was $465.00K, a 2013.64% increase year-over-year.
- Spruce Biosciences, Inc. interest expense, long-term debt for the quarter ending 2026-03-31 was $158.00K, a 426.67% increase year-over-year.
- Spruce Biosciences, Inc. interest expense, long-term debt for the quarter ending 2025-06-30 was $22.00K.
- Spruce Biosciences, Inc. interest expense, long-term debt for the quarter ending 2025-03-31 was $30.00K.
| Period end | Interest Expense, Long-term Debt 3 month | Interest Expense, Long-term Debt 6 month |
|---|---|---|
| 2026-06-30 | $465.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $623.00K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $158.00K 10-Q · filed 2026-05-13 | |
| 2025-06-30 | $22.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $52.00K 10-Q · filed 2026-08-12 |
| 2025-03-31 | $30.00K 10-Q · filed 2026-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |